WXB-26618-00368

3 vaccinations 5 coded responses 26 check-ins 4 free-text entries 2 call cases

Sex: —
Age at first dose: 26-30
ZIP prefix: 021 / MA
Registered: 2021-03-22

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-22
Registered in v-safe
2021-03-22
Dose 1 — Pfizer-BioNTech
2021-03-22
Survey response — day 0, dose 1
MedDRA: Alcohol intolerance, Hyperhidrosis — Feeling: Fair · Fever · Joint pains, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: Sweats and decreased alcohol tolerance.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-23
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-03-24
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-03-25
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-03-26
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-03-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-28
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-03-29
Health check-in — day 7, dose 1
Feeling: Fair · Joint pains, Muscle or body aches · Be unable to do your normal daily activities

Adult check-in
2021-04-05
Health check-in — day 14, dose 1
Feeling: Fair

Adult check-in
2021-04-12
Dose 2 — Pfizer-BioNTech
2021-04-12
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain, Swelling · None

Adult check-in
2021-04-13
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-04-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-04-15
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Swelling · Joint pains, Muscle or body aches

Adult check-in
2021-04-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-18
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache

Adult check-in
2021-04-19
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-04-26
Survey response — day 14, dose 2
MedDRA: Detoxification, Drug abuse, Pre-existing disease, Unevaluable event — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization

Free text: Symptoms: Drug relapse · Healthcare visit (other): Detox

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-26
Report sent to call center — day 14, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-05-03
Health check-in — day 21, dose 2
Feeling: Fair

Adult check-in
2021-05-10
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-17
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-05-24
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-12
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-11
Survey response — 6 months, dose 2
MedDRA: Productive cough — Feeling: Fair

Free text: Wet cough, increased phlegm production

MedDRA releases: 2024-11 · check-in free text available
2021-12-30
Call successful
Participant prefers to complete VAERS report online
2022-01-19
Dose 3 — Pfizer-BioNTech
2022-04-12
Survey response — 12 months, dose 2
MedDRA: Migraine, Pre-existing disease — Feeling: Fair · Be unable to work or attend school

Free text: Migraines, severe seasonal allergy

MedDRA releases: 2024-11 · check-in free text available
2022-04-25
Health check-in — 3 months, dose 3
Feeling: Poor

Adult check-in
2023-01-19
Survey response — 12 months, dose 3
MedDRA: Abdominal pain upper, Vomiting — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2024-11
2023-01-19
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2023-01-20
Call successful
Participant prefers to complete VAERS report online

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-22	Pfizer-BioNTech
2	2021-04-12	Pfizer-BioNTech
3	2022-01-19	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-04-26	Successful 2021-12-30	Participant prefers to complete VAERS report online
2023-01-19	Successful 2023-01-20	Participant prefers to complete VAERS report online

Free text

Release 6 — day 0, dose 1

2021-03-22

Systemic reaction (other): Sweats and decreased alcohol tolerance.

Release 8 — day 14, dose 2

2021-04-26

Symptoms: Drug relapse

Healthcare visit (other): Detox

Release 10 — 6 months, dose 2

2021-10-11

Symptoms: Wet cough, increased phlegm production

Release 11 — 12 months, dose 2

2022-04-12

Symptoms: Migraines, severe seasonal allergy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Detoxification	✓	·	✓
HCVO	Unevaluable event	○	✓	○
SD	Abdominal pain upper	·	·	✓
SD	Drug abuse	✓	·	✓
SD	Migraine	·	·	✓
SD	Pre-existing disease	✓	·	✓
SD	Productive cough	·	·	✓
SD	Unevaluable event	○	✓	○
SD	Vomiting	·	·	✓
SRO	Alcohol intolerance	✓	·	✓
SRO	Hyperhidrosis	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release